Founder Factory Featured IP

These Featured Innovations are a curated set of promising technologies from regional research institutions selected by Founder Factory for startup exploration. Each offers strong technical foundations and early commercial potential. We’re bringing together interdisciplinary teams to explore viable paths to new venture creation.

Join us on May 28th at the Founder Factory Technology Pitch Event

to Help Build the Next Startup Around These Innovations.

AI & Data Science

UWMRF_logo_crop

Protecting real‑world AI before it’s exploited

Secure‑by‑Design AI for Edge Devices

As AI moves onto cameras, robots, and sensors, security must be built in—not bolted on. By embedding protection directly into edge operation, this on‑device software helps defend against malicious attacks, reducing risk and enabling broader, safer adoption of AI beyond controlled environments.

mcw logo

Building Trustworthy AI for High‑Stakes Decisions

Understanding AI Systems Before They Fail

As AI systems shape critical, real‑world decisions, knowing how they behave before problems arise becomes essential. This innovation points toward a future where teams can inspect and validate AI models in use—building confidence, catching issues earlier, and enabling safer deployment in high‑stakes environments.

Health and Bio

versiti-logo-4c

Front-Line Antiviral Protection Platform

Stopping Respiratory Infections Before They Take Hold

This intranasal platform reimagines antiviral protection by acting at the body’s front line—where respiratory viruses begin infection. By anchoring protection directly to airway cells, it enables longer‑lasting defense and a flexible approach that can be rapidly adapted to new and emerging viral threats.

versiti-logo-4c

Lipid‑Lowering Peptide for Cardiovascular Disease

Addressing the heart‑disease risk that today’s drugs leave behind

Even with medication, millions remain at risk for cardiovascular events. This innovation points toward a new class of therapies that address the full range of harmful blood lipoproteins—opening more complete and durable protection for patients underserved by today’s standard treatments.

mcw logo

Next‑Generation Lyme Disease Vaccine

Longer‑term protection for people and pets at risk

As Lyme risk continues to expand, this innovation points toward a new generation of vaccines designed for durability—not short‑lived immunity. The approach aims to provide broader, longer‑term protection for both people and pets in regions where Lyme disease is becoming a persistent and growing threat.

UWM_logo_crop-1

Ultra‑Rapid On‑Site Detection of Foodborne Pathogens

Real‑time insight for safer food production

This Today’s food safety systems often catch problems too late. This innovation points toward a future where pathogens are detected on‑site in near real time—helping producers prevent contamination, reduce recalls, and gain clearer visibility into food safety across the supply chain.

Industrial Technologies

UWMRF_logo_crop

Low‑Cost Surface Alloying for Copper & Brass Castings

Improving corrosion resistance and safety in critical metal components

This technology enables foundries to produce safer, more durable copper and brass components by selectively upgrading surface performance. It improves corrosion resistance and reduces lead leaching using existing foundry processes—delivering higher‑quality products without changing bulk alloys or investing in new equipment.

Medical Device and Imaging

Augmented Reality‑Guided MRI Procedures

Making MRI‑guided care clearer, faster, and safer

By giving clinicians GPS‑like visual cues inside the MRI, this technology points toward a new standard for image‑guided care—where procedures are more precise, take less time, and place less burden on both patients and clinical teams.

Adaptive Dose‑Tracking Software for Radiation Therapy

A truer picture of radiation dose for individualized cancer care

Help evaluate a software innovation that accurately tracks radiation dose as patient anatomy changes—offering safer, more precise treatment assessment than static dose‑summation methods. Perfect for participants with experience in radiation oncology, medical imaging, clinical software, or digital health to examine market fit and startup potential.

Interested in a Technology? Reach out to us to learn more!